No differences in chemerin and CMKLR1 expression levels could be observed between tumor subgroups with different levels of ERα, nuclear ERβ, PR, CEA, CA125, CA72-4, p53, Her2, or EGFR. This evidence concerns the gene ERBB2 and neoplasm.